Shilling for Stem Cell Treatments? A Look at the Journal Nature and an Advertising Matter
For UC Davis scientist, Paul Knoepfler it was something "very strange." For Pulitzer Prize-winning Los Angeles Times columnist Michael Hiltzik, it had the earmarks of a "race to the bottom."
And it all involved a stem cell matter published by the prestigious journal Nature.
The headline on Hiltzik's column yesterday summarized the case like this.
"Did a w…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.